ACER »
VHIO joins seven other international institutions in a consortium led by AMGEN to accelerate the development and application of new therapies in the treatment of cancer
Amgen (NASDAQ:AMGN) today announced the launch of Amgen Partners of Choice (APoC), a new network that brings together Amgen’s oncology research and development experts and world-class clinical leaders at eight research centers across the globe. The APoC member institutions are Asan Medical Center (Seoul, South Korea), Dana-Farber Cancer Institute (Boston, Mass.), Essen University Hospital (Essen, … Read more